124 related articles for article (PubMed ID: 36924309)
1. Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Robsahm TE; Falk RS; Eide NA
Acta Ophthalmol; 2023 Sep; 101(6):696-704. PubMed ID: 36924309
[TBL] [Abstract][Full Text] [Related]
2. Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up.
Wróblewska-Zierhoffer M; Paprzycka B; Kubiak A; Tomczyk Ł; Rospond-Kubiak I
BMC Ophthalmol; 2023 Dec; 23(1):506. PubMed ID: 38087265
[TBL] [Abstract][Full Text] [Related]
3. Characterizations of uveal melanoma patients with three additional primary malignancies.
Eide NA; Faber RT; Garred Ø; Sørum Falk R; Robsahm TE
Acta Ophthalmol; 2024 Jan; ():. PubMed ID: 38229427
[TBL] [Abstract][Full Text] [Related]
4. Uveal metastasis revealing lung cancer.
Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
6. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma-associated cancers revisited.
Alfaar AS; Saad A; Elzouki S; Abdel-Rahman MH; Strauss O; Rehak M
ESMO Open; 2020 Nov; 5(6):e000990. PubMed ID: 33257317
[TBL] [Abstract][Full Text] [Related]
8. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
9. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
Zhou N; Zhang R; Liu Y; Wei W
Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
12. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.
Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M
Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).
Mahendraraj K; Lau CS; Lee I; Chamberlain RS
Clin Ophthalmol; 2016; 10():2113-2119. PubMed ID: 27822007
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
[TBL] [Abstract][Full Text] [Related]
17. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
18. Uveal and conjunctival melanomas: disease course and outcomes in Chinese patients.
Chan JYY; Lam SC; Yuen HKL
Hong Kong Med J; 2023 Dec; 29(6):506-513. PubMed ID: 38044329
[TBL] [Abstract][Full Text] [Related]
19. Primary bilateral uveal melanoma: a population-based study and systematic review.
Scott JF; Vyas R; Galvin J; Gotow E; Fiessinger L; Gerstenblith AT; Gerstenblith MR
Clin Exp Ophthalmol; 2018 Jul; 46(5):502-510. PubMed ID: 29219254
[TBL] [Abstract][Full Text] [Related]
20. Very long-term prognosis of patients with malignant uveal melanoma.
Kujala E; Mäkitie T; Kivelä T
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4651-9. PubMed ID: 14578381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
